X-linked severe syndromic thoracic aortic aneurysm and dissection Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for X-linked severe syndromic thoracic aortic aneurysm and dissection.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Horizant

Azurity

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Horizant

(gabapentin enacarbil)Orphan drugstandard

Arbor Pharmaceuticals, LLC

12.1 Mechanism of Action Gabapentin enacarbil is a prodrug of gabapentin and, accordingly, its therapeutic effects in RLS and PHN are attributable to ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for X-linked severe syndromic thoracic aortic aneurysm and dissection.
Search all trials →

Search clinical trials for X-linked severe syndromic thoracic aortic aneurysm and dissection →

Recent News & Research

No recent news articles indexed yet for X-linked severe syndromic thoracic aortic aneurysm and dissection.
Search PubMed for X-linked severe syndromic thoracic aortic aneurysm and dissection →

Browse all X-linked severe syndromic thoracic aortic aneurysm and dissection news →

Specialist Network

No specialists currently listed for X-linked severe syndromic thoracic aortic aneurysm and dissection.

View all X-linked severe syndromic thoracic aortic aneurysm and dissection specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰